[Cystatin C and cardiovascular risk].

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Russian Clinical Laboratory Diagnostics

• Publication date

  2012-10-01

• Fields of study

  Medicine

• Identifiers
  PMID 23265063
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cystatin C in acute heart failure without advanced renal impairment.

  2009cited by this paper
• Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study.

  2009cited by this paper
• Factors other than glomerular filtration rate affect serum cystatin C levels.

  2009cited by this paper
• Differential estimation of CKD using creatinine- versus cystatin C-based estimating equations by category of body mass index.

  2009cited by this paper
• Cystatin C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin T.

  2009cited by this paper
• Serum cystatin C and increased coronary heart disease prevalence in US adults without chronic kidney disease.

  2008cited by this paper
• Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.

  2008cited by this paper
• Impact of Kidney Disease and Blood Pressure on the Development of Cardiovascular Disease: An Overview From the Japan Arteriosclerosis Longitudinal Study

  2008cited by this paper
• Differences in Kidney Function and Incident Hypertension: The Multi-Ethnic Study of Atherosclerosis

  2008cited by this paper
• Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.

  2008cited by this paper
• Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study).

  2008cited by this paper
• Multi-Ethnic Study of Atherosclerosis (MESA)

  2008cited by this paper
• Cystatin C as a Risk Factor for Outcomes in Chronic Kidney Disease

  2007cited by this paper
• Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study.

  2007cited by this paper
• Prevalence of chronic kidney disease in the United States.

  2007cited by this paper
• Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children--a meta-analysis.

  2007cited by this paper
• Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study.

  2007cited by this paper
• Association of Cystatin C With Mortality, Cardiovascular Events, and Incident Heart Failure Among Persons With Coronary Heart Disease: Data From the Heart and Soul Study

  2006cited by this paper
• GFR estimation using cystatin C is not independent of body composition.

  2006cited by this paper
• Cystatin C and Prognosis for Cardiovascular and Kidney Outcomes in Elderly Persons without Chronic Kidney Disease

  2006cited by this paper
• Destabilizing Role of Cathepsin S in Murine Atherosclerotic Plaques

  2006cited by this paper
• Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP.

  2006cited by this paper
• Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease.

  2005cited by this paper
• Disruption of the Cathepsin K Gene Reduces Atherosclerosis Progression and Induces Plaque Fibrosis but Accelerates Macrophage Foam Cell Formation

  2005cited by this paper
• Cystatin-C and mortality in elderly persons with heart failure.

  2005cited by this paper
• Cystatin C and the risk of death and cardiovascular events among elderly persons.

  2005cited by this paper
• Genotype and Plasma Concentration of Cystatin C in Patients With Coronary Heart Disease and Risk for Secondary Cardiovascular Events

  2005cited by this paper
• Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate.

  2005cited by this paper
• Lack of the Cysteine Protease Inhibitor Cystatin C Promotes Atherosclerosis in Apolipoprotein E–Deficient Mice

  2005cited by this paper
• Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children.

  2005cited by this paper
• Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study.

  2005cited by this paper
• Cystatin C Concentration as a Risk Factor for Heart Failure in Older Adults

  2005cited by this paper
• Cystatin-C and inflammatory markers in the ambulatory elderly.

  2005cited by this paper
• Thyroid function differently affects serum cystatin Cand creatinine concentrations

  2005cited by this paper
• A cystatin C‐based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft‐Gault formula

  2005cited by this paper
• Lysosomal Cysteine Proteases in Atherosclerosis

  2004cited by this paper
• Cysteine Protease Cathepsin F Is Expressed in Human Atherosclerotic Lesions, Is Secreted by Cultured Macrophages, and Modifies Low Density Lipoprotein Particles in Vitro*

  2004cited by this paper
• Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

  2004cited by this paper
• Human Evidence That the Cystatin C Gene Is Implicated in Focal Progression of Coronary Artery Disease

  2004cited by this paper
• Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.

  2004cited by this paper
• Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement.

  2004cited by this paper
• The Prevalence of Nontraditional Risk Factors for Coronary Heart Disease in Patients with Chronic Kidney Disease

  2004cited by this paper
• Estimation of glomerular filtration rates before and after orthotopic liver transplantation: Evaluation of current equations

  2004cited by this paper
• Cystatin C: A Novel Predictor of Outcome in Suspected or Confirmed Non–ST-Elevation Acute Coronary Syndrome

  2004cited by this paper
• Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study.

  2003cited by this paper
• Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

  2003cited by this paper
• Estimation of Glomerular Filtration Rate in Older Patients with Chronic Renal Insufficiency: Is the Modification of Diet in Renal Disease Formula an Improvement?

  2003cited by this paper
• Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

  2003cited by this paper
• Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease.

  2003cited by this paper
• Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency.

  2002cited by this paper
• clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification

  2002cited by this paper
• Multi-Ethnic Study of Atherosclerosis: objectives and design.

  2002cited by this paper
• Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis.

  2002cited by this paper
• K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

  2002cited by this paper
• Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients.

  2001cited by this paper
• Cystatin C deficiency in human atherosclerosis and aortic aneurysms.

  1999cited by this paper
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

  1999cited by this paper
• Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells.

  1998cited by this paper
• The Cardiovascular Health Study: design and rationale.

  1991cited by this paper
• Modulation of phagocytosis-associated respiratory burst by human cystatin C: role of the N-terminal tetrapeptide Lys-Pro-Pro-Arg.

  1990cited by this paper
• Efficient production of native, biologically active human cystatin C by Escherichia coli

  1988cited by this paper
• An investigation of coronary heart disease in families. The Framingham offspring study.

  1979cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper

• Serum Cystatin C: An Innovative Biomarker for Early Renal Impairment in Diabetes

  2026cites this paper
• High-dimensional machine learning models for prediction of heart failure in more than 400 000 men and women from the UK Biobank

  2025cites this paper
• Cystatin C as a Biomarker for Identifying High-Risk Patients with Acute Coronary Syndrome: An Observational Study

  2025cites this paper
• CYSTATIN C AS A MARKER OF EARLY KIDNEY DAMAGE UNDER ARTERIAL HYPERTENSION (LITERATURE REVIEW)

  2024cites this paper
• Study of the Level of Cystatin C in Type 2 Diabetes Mellitus with Obesity

  2023cites this paper
• Evidence of increased vascular stiffness and left ventricular hypertrophy in children with cystic kidney disease

  2023cites this paper
• Dietary Mg Supplementation Decreases Oxidative Stress, Inflammation, and Vascular Dysfunction in an Experimental Model of Metabolic Syndrome with Renal Failure

  2023cites this paper
• Cardiovascular risk prediction using metabolomic biomarkers and polygenic risk scores: A cohort study and modelling analyses

  2023cites this paper
• Paracrine Signals in Calcified Conditioned Media Elicited Differential Responses in Primary Aortic Vascular Smooth Muscle Cells and in Adventitial Fibroblasts

  2023cites this paper
• Cystatin C to Left Ventricular Ejection Fraction Ratio as a Novel Predictor of Adverse Outcomes in Patients with Coronary Artery Disease: A Prospective Cohort Study

  2023cites this paper
• Perioperative acute kidney injury: impact and recent update

  2022cites this paper
• Increased serum cystatin C levels and responses of pancreatic α- and β-cells in type 2 diabetes

  2022cites this paper
• Lipocalin-2, S100A8/A9, and cystatin C: Potential predictive biomarkers of cardiovascular complications in COVID-19

  2022cites this paper
• Early detection of acute renal failure by serum cystatin C in type 2 diabetes patients in Parul Sevashram hospital at Waghodia, Vadodara

  2022influential citation
• Association of Serum Cystatin C Levels with Disease Severity in Patients with Acute Coronary Syndrome

  2021cites this paper
• Comparative study of various glomerular filtration rate estimating equations in Egyptian patients with hepatitis C virus-related liver cirrhosis: a single-center observational study

  2021cites this paper
• Gestational and Age-Specific Cystatin C Reference Intervals for Newborns

  2021cites this paper
• Serum Cystatin C Level as a Biomarker of Aortic Plaque in Patients with an Aortic Arch Aneurysm

  2020cites this paper
• Renal Equations Using Cystatin C and Creatinine in Correlation to Lipids in Chronic Kidney Disease - A Cross-Sectional Study

  2020cites this paper
• Cystatin C and its Twin Position in Estimating Renaland Cardiovascular Fame; An Overview

  2020cites this paper
• Assessment of Serum Creatinine, Cystatin C and Neutrophil Gelatinase-associated Lipocalin Levels in Rosacea: A Case-Control Study

  2020cites this paper
• To Compare the Level of Cystatin C in Type 2 Diabetes Mellitus with Obesity

  2020cites this paper
• Serum Cystatin C, a Sensitive Marker of Renal Function and Cardiovascular Disease, Decreases After Smoking Cessation

  2019cites this paper
• The Value of a Cystatin C-based Estimated Glomerular Filtration Rate for Cardiovascular Assessment in a General Japanese Population: Results From the Iwate Tohoku Medical Megabank Project

  2019cites this paper
• Muscular Strength is Independently Associated with Cystatin C: The KORA-Age Study

  2018cites this paper
• CHAPTER 10 Plasma Cystatin C and Neutrophil Gelatinase-Associated Lipocalin in Relation to Coronary Atherosclerosis on Intravascular Ultrasound and Cardiovascular Outcome Impact of Kidney Function The AtheroRemo-IVUS Study

  2018cites this paper
• Značaj cistatina C kao faktora rizika za kardiovaskularne bolesti kod oboljelih od tipa 2 diabetes mellitus-a

  2018cites this paper
• Utilidade clínica da Cistatina C para avaliação do prognóstico das Síndromes Coronarianas Agudas: uma revisão sistemática e metanálise

  2018cites this paper
• Risk factors for diastolic left ventricular myocardial dysfunction in patients with chronic kidney disease.

  2018cites this paper
• 10 Genetics of Endothelial Damage Associated to Diabetes Mellitus Type 2

  2018cites this paper
• Cystatin C Is a More Reliable Biomarker for Determining eGFR to Support Drug Development Studies

  2018cites this paper
• Can Serum Cystatin C predict long-term survival in cardiac surgery patients?

  2018cites this paper
• Reduced coronary collateralization in type 2 diabetic patients with chronic total occlusion

  2018cites this paper
• Clinical Usefulness of Cystatin C to Assess the Prognosis of Acute Coronary Syndromes: A Systematic Review and Meta-Analysis

  2018cites this paper
• Assessment of nephroprotective action of angiotensin-converting enzyme inhibitor ramipril in patients with chronic glomerulonephritis

  2017influential citation
• Association between high cystatin C levels and carotid atherosclerosis

  2017cites this paper
• Importance of cystatin C and uric acid levels in the association of cardiometabolic risk factors in Japanese junior high school students.

  2017cites this paper
• The short and medium term effects of Endovascular Aneurysm Repair (EVAR) on coagulation, fibrinolysis and renal function in patients with Abdominal Aortic Aneurysms

  2017cites this paper
• Novel biomarkers with potential for cardiovascular risk reclassification

  2017influential citation
• Cystatin C is a useful predictor of early neurological deterioration following ischaemic stroke in elderly patients with normal renal function

  2017influential citation
• Can biomarker predict development and progression of pulmonary artery hypertension?

  2017cites this paper
• [Renal function estimation formulas in predicting long-term cardiovascular outcomes in patients with myocardial infarction concurrent with diabetes mellitus].

  2016cites this paper
• Effects of thyroid hormone withdrawal on metabolic and cardiovascular parameters during radioactive iodine therapy in differentiated thyroid cancer

  2016cites this paper
• Cystatin C in healthy middle-aged adults: A relationship with anthropometric and cardiometabolic parameters

  2016cites this paper
• Comparison of Risk Prediction With the CKD‐EPI and MDRD Equations in Non–ST‐Segment Elevation Acute Coronary Syndrome

  2016cites this paper
• Novel Biomarkers for Renal Diseases? None for the Moment (but One)

  2016cites this paper
• Cystatin C Levels in Middle-Aged Patients with Obstructive Sleep Apnea Syndrome

  2016cites this paper
• Serum and Urinary Biomarkers Endothelin-1, Beta-2 Microglobulin, Cystatin C, Galectin-3 and Alpha-1-acid Glycoprotein; Can they Surrogate Clinical and Histological Staging in Lupus Nephritis Patients?

  2016cites this paper
• Plasma cystatin C and neutrophil gelatinase-associated lipocalin in relation to coronary atherosclerosis on intravascular ultrasound and cardiovascular outcome: Impact of kidney function (ATHEROREMO-IVUS study).

  2016cites this paper
• Serum Cystatin C and the Risk of Coronary Heart Disease in Ethnic Chinese Patients With Normal Renal Function.

  2016cites this paper
• Cystatin C and Cardiovascular Disease: Causality, Association, and Clinical Implications of Knowing the Difference.

  2016cites this paper
• Serum Galectin and Renal Dysfunction in ST-Segment Elevation Myocardial Infarction

  2016cites this paper
• Cystatin C: A new biochemical marker in livestock sector -

  2016cites this paper
• Cystatin C, Age and Gender in Healthy African Black Adults: Ivorian Exemple

  2016cites this paper
• Estimating glomerular filtration rate in acute coronary syndromes: Different equations, different mortality risk prediction

  2016cites this paper
• Cystatin Levels in a Rural South Indian Population

  2016cites this paper
• Renal biomarkers for the prediction of cardiovascular disease

  2015cites this paper
• Cystatin C Is Not Causally Related to Coronary Artery Disease

  2015cites this paper
• Clinical significance of cystatin C in acute coronary syndromes : is it really more than a marker of renal function ?

  2015cites this paper
• Cystatin C as a marker of Cardio metabolic disorder in obese South Indian individuals

  2015cites this paper
• Cystatin C predicts diabetic retinopathy in Chinese patients with type 2 diabetes

  2015cites this paper
• Conformational transitions induced by in vitro macromolecular crowding lead to the amyloidogenesis of buffalo heart cystatin

  2015cites this paper
• Biomarkers of renal function, which and when?

  2015cites this paper
• Platelet-derived miR-92a downregulates cysteine protease inhibitor cystatin C in type II diabetic lower limb ischemia.

  2015cites this paper
• Protective effects of purslane seed (Portulaca Oleracea L.) on plasma levels of Cystatin C, Cathepsin S, and Creatinine in women with type 2 Diabetes

  2015cites this paper
• Ankle-brachial index, risk of clinical fractures, mortality and low bone mass in nursing home residents.

  2015cites this paper
• Association of Obesity with Serum Cystatin C in Korean Adults

  2015cites this paper
• The Association of Serum Cystatin C with Glycosylated Hemoglobin in Korean Adults

  2015cites this paper
• Correlation of Cystatin C with Atherogenic Indices in South Indian Obese Individuals

  2015cites this paper
• Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes.

  2015cites this paper
• Serum cystatin C and neutrophil gelatinase-associated lipocalin in predicting the severity of coronary artery disease in diabetic patients

  2015cites this paper
• CYSTATIN C - MORE THAN THE MARKER OF THE GLOMERULAR FILTRATION RATE.

  2015cites this paper
• Serum Cystatin C Reflects Angiographic Coronary Collateralization in Stable Coronary Artery Disease Patients with Chronic Total Occlusion

  2015cites this paper
• A Cluster of Proteins Implicated in Kidney Disease Is Increased in High-Density Lipoprotein Isolated from Hemodialysis Subjects.

  2015cites this paper
• Crosstalk of Various Biomarkers That Might Provide Prompt Identification of Acute or Chronic Cardiorenal Syndromes

  2015cites this paper
• Cathepsin S: therapeutic, diagnostic, and prognostic potential

  2015cites this paper
• CORONARY INTERVENT IONS

  2015cites this paper
• Prospective observational study to evaluate risk factors for falls in institutionalized elderly people: the role of cystatin C

  2015cites this paper
• Clinical analysis of the relationship between cystatin C and metabolic syndrome in the elderly.

  2014cites this paper
• Serum cystatin C levels are associated with coronary artery disease and its severity.

  2014cites this paper
• Serum Amyloid A as a Marker of Persistent Inflammation and an Indicator of Cardiovascular and Renal Involvement in Patients with Rheumatoid Arthritis

  2014cites this paper
• Time course changes of cystatin C and inflammatory and biochemical markers in non-ST-elevation acute coronary syndromes

  2014cites this paper
• Uncovering the cathepsin system in heart failure patients submitted to Left Ventricular Assist Device (LVAD) implantation

  2014cites this paper
• Clinical Utility of Serum Cystatin C in Predicting Coronary Artery Disease in Patients Without Chronic Kidney Disease

  2014cites this paper
• Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus

  2014cites this paper
• RETRACTED ARTICLE: The role of cystatin C in vascular remodeling of balloon-injured abdominal aorta of rabbits

  2014cites this paper
• CLINICAL ANALYSIS OF ASSOCIATION OF CYSTATIN C AND ATRIAL FIBRILLATION

  2014cites this paper
• Einfluss von Schlafapnoe auf das kardiovaskuläre Risikoprofil bei Hypertonikern

  2014cites this paper
• Novel biomarkers in heart failure: usefulness in clinical practice

  2014cites this paper
• Proteomics Analysis of Lungs from Somatic Cell Nuclear Transfer (SCNT) Bama Miniature Pig (Sus scrofa)

  2014cites this paper
• Estimated glomerular filtration rate in diabetic patients

  2014cites this paper
• Serum cystatin C concentration as an independent marker for hypertensive left ventricular hypertrophy

  2013cites this paper
• Biomarkers of Renal Function in Acute Coronary Syndromes

  2013influential citation
• Cystatin C in children on chronic hemodialysis

  2013cites this paper
• Circulating Biomarkers for Predicting Cardiovascular Disease Risk; a Systematic Review and Comprehensive Overview of Meta-Analyses

  2013cites this paper
• Cystatin C in Acute Coronary Syndrome

  2013cites this paper
• Unique properties of cluster of differentiation 93 in the umbilical cord blood of neonates

  2013cites this paper
• Low molecular mass proteins as markers for renal function and dialysis efficiency

  2013cites this paper
• Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

  2013cites this paper
• Cystatin C- and creatinine-based estimates of renal function and their value for risk prediction in patients with acute coronary syndrome: results from the PLATelet Inhibition and Patient Outcomes (PLATO) study.

  2013cites this paper